ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,561.69
0.96%
US Tech 100
19,851.20
1.07%
Dow Jones
39,323.35
0.04%
Brent Oil
86.485
-0.97%
Bitcoin
56,436.21
-0.95%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) News

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc (VNDA)

NASDAQ
5.25
-0.11
( -2.05% )
Updated: 14:10:33
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

VNDA News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2024
VNDA (-2.05%)

Form 8-K - Current report
Edgar (US Regulatory)
June 06 2024
VNDA (-2.05%)

Form 8-K - Current report
Edgar (US Regulatory)
May 24 2024
VNDA (-2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 24 2024
VNDA (-2.05%)

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
May 24 2024
VNDA (-2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 21 2024
VNDA (-2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 21 2024
VNDA (-2.05%)

VNDA Discussion

View Posts
Monksdream Monksdream 1 day ago
VNDA under $10
👍️0
Monksdream Monksdream 4 weeks ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 4 weeks ago
Over $6
👍️0
tw0122 tw0122 4 weeks ago
Vanda acquired U.S. and Canadian rights to PONVORY® from a Johnson & Johnson Company on December 7, 2023. PONVORY® is approved by the U.S. Food and Drug Administration (FDA) and Health Canada to treat adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease (RMS).

In anticipation of the commercial launch of PONVORY® for RMS in the third quarter of 2024, Vanda is initiating a host of commercial activities including the creation of a specialty sales force, a prescriber awareness program and a comprehensive marketing program.
👍️0
harry crumb harry crumb 2 months ago
Gonna be a winner. Patience
👍️0
harry crumb harry crumb 2 months ago
Over 5$!
👍️0
Monksdream Monksdream 2 months ago
VNDA under $5
👍️0
harry crumb harry crumb 2 months ago
Let er rip $$$$$$$$
👍️0
Tiger Money Tiger Money 3 months ago
Agreed. This could double quickly
👍️0
philaya philaya 3 months ago
got this today...
very good trades.
👍️0
harry crumb harry crumb 3 months ago
This little gem could run up fast, they obviously have their science going in the right direction as the offers are there just not the price, could be a 10.00 offer in the works
👍️0
morokoy morokoy 3 months ago
Shares Outstanding 57,537,499 shares
Insider Shares 7,908,897 shares
Insider Ownership 13.75 %
Total Insiders 34
👍️0
morokoy morokoy 3 months ago
"The dividend distribution of rights will be payable to stockholders of record as of the close of business on April 29, 2024."

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends.

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends. You should receive a Form 1099-DIV, Dividends and Distributions from each payer for distributions of at least $10.

Guess we'll have to wait on the promised 8K.

Additional details of the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The filing will be available on the SEC's website at www.sec.gov.
👍️0
harry crumb harry crumb 3 months ago
Minimum 8$ imo
👍️0
MiamiGent MiamiGent 3 months ago
Vanda Pharmaceuticals rejects takeover proposal from Future Pak
REUTERS
1 mins ago
April 17 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.NaE) on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues the company.

(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
👍️0
Monksdream Monksdream 3 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️ 1
MiamiGent MiamiGent 3 months ago
Probably...but I took it at 5.49
👍️0
Monksdream Monksdream 3 months ago
Will it grow legs after 9:30
👍️0
MiamiGent MiamiGent 3 months ago
VNDA Vol picking up..

$5.49 +$1.44 (+35.56%)

Volume 3,354,569

90 DAV... 2M
👍️0
MiamiGent MiamiGent 3 months ago
VNDA Here we go
$5.3781 +$1.3281 (32.79%)

Bid ARCX
5.36 x 10
Ask XNMS
5.38 x 11
Volume
2,971,106
👍️0
MiamiGent MiamiGent 3 months ago
VNDA Vol is good. Already @ 90 DAV
Volume 2,056,421
10/90-day avg. volume
7M / 2M
👍️0
MiamiGent MiamiGent 3 months ago
VNDA Good post, Laster.
https://www.futurepak.com/
👍️0
Laster Laster 3 months ago
The major question is who is Future Pak really?
Is this a legit offer?
Either way, company is extremely undervalued with no debt (I believe) and lots of cash.
Large short position. Lots of selling PM at $5.
Market does not seem to believe this offer. Sorry.
👍️0
MiamiGent MiamiGent 3 months ago
VNDA Float 52.05M

Shares Short (3/28/2024) 2.49M
Short Ratio (3/28/2024) 2.78
Short % of Float (3/28/2024) 5.45%
👍️0
MiamiGent MiamiGent 3 months ago
VNDA
Bid EDGX
4.85 x 3
Ask EDGX
4.88 x 3

Volume
1,790,654
Avg Vol (10 day) 6.63M
👍️0
MiamiGent MiamiGent 3 months ago
Vanda Pharmaceuticals
Closed .01 (-0.25%)

Pre-market
$5.15 +1.10 (+27.16%)
As of Apr-17-2024 7:23:52 AM ET
Bid x size $5.14 x 1
Ask x size $5.16 x 3
👍️0
MiamiGent MiamiGent 3 months ago
VNDA In 5.12. Let's see, said the blind man.
👍️0
MiamiGent MiamiGent 3 months ago
Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
Apr. 17, 2024 6:41 AM ETVanda Pharmaceuticals Inc. (VNDA) Stock
👍️0
MiamiGent MiamiGent 3 months ago
What's the news?
👍️0
Awl416 Awl416 3 months ago
Damn
👍️0
Monksdream Monksdream 3 months ago
Will it grow legs after 9:30
👍️0
Monksdream Monksdream 3 months ago
Will it grow legs after 9:30
👍️0
tknuncle tknuncle 5 months ago
I have been acquiring since $3.90. I wish that I would have waited longer lol but, like what I see with VNDA. Was going to grab the last of my starter position soon. GLTA
👍️0
weedtrader420 weedtrader420 5 months ago
FDA Approve
👍️0
Triple nickle Triple nickle 7 months ago
Fda accepts new drug application for tradipitant in the after hours today
👍️ 1
jgrabar jgrabar 2 years ago
$VNDA -On May 19, 2022, Vanda Pharmaceuticals agreed to settle a securities fraud class action complaint (the “Complaint”) for $11.5 Million. https://grabarlaw.com/the-latest/vanda-pharmaceuticals-investigation/
👍️0
RNsidersbuying RNsidersbuying 4 years ago
VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen
👍️0
XenaLives XenaLives 4 years ago
Everything would be a lot better if the govt. would just let doctors treat COVID like another flu bug. The drama is getting old.
👍️0
Peepson Peepson 4 years ago
Yo, this thing is going to trade sideways for a while. They have a drug that could help with covid but so does every other pharma company. Its a safe hold imo but nothing will happen fast i don't think
👍️0
XenaLives XenaLives 4 years ago
What's up? Doesn't seem to be much interest. I was looking at the chart but haven't found much on the company yet.

👍️0
otcmoneydoubler otcmoneydoubler 4 years ago
LOL. VNDA GOT NEWS TODAY. SO WHAT DD HAVE YOU GOT TO SHARE?
👍️0
Peepson Peepson 4 years ago
Yo, does anyone still follow this board. I might have some interesting dd to share.
👍️0
bezen bezen 7 years ago
https://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html
👍️0
Coz Mabluda Coz Mabluda 8 years ago
Brett Jensen. SA article re VNDA. Expects positive analyst's review.

Vanda Pharmaceuticals (NASDAQ:VNDA) posted solid third quarter results on Thursday. Instead of losing a dime a share as expected, the company posted a profit of 11 cents a share. Revenue was also up more than 35% from the same period a year ago. The company now looks like it could be profitable in FY2017. I expect some positive analyst commentary on this name by analysts over the next week. Vanda has a solid pipeline and over $140 million in cash and marketable securities on the balance sheet. One has to like the company's growth trajectory and the concern seems undervalued with just a $600 million market capitalization.



👍️0
stocktrademan stocktrademan 8 years ago
fast and steady profit scan VNDA bullish 16.64



normal chart


log chart

👍️0
ClearlyStocks ClearlyStocks 8 years ago
VNDA $16.74
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$VNDA $16 from $14 now
👍️0
nyctraydr nyctraydr 8 years ago
Where Things Stand For Vanda Pharmaceuticals In Fanapt Patent Suit http://marketexclusive.com/things-stand-vanda-pharmaceuticals-inc-nasdaqvnda-fanapt-patent-suit/24951/?icd1
👍️0
ClayTrader ClayTrader 8 years ago
* * $VNDA Video Chart 08-25-16 * *

Link to Video - click here to watch the technical chart video
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$15.24 weeee
👍️0

Your Recent History

NASDAQ
VNDA
Vanda Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved